Faeth Therapeutics To Conduct Virtual Event On Nov. 9 To Present Topline Data From Its Phase 2 PIK-2-1 Study Of PIKTOR To Treat Endometrial Cancer
Benzinga Newsdesk 4 hours ago
News
Faeth Therapeutics (NASDAQ:FTH), a clinical- stage biotechnology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that it will host a virtual event on
Faeth Therapeutics (NASDAQ:FTH), a clinical- stage biotechnology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that it will host a virtual event on Monday, November 9 at 8:00 AM ET to discuss topline results from its Phase 2 PIK-201 trial exploring PIKTOR in advanced endometrial cancer.